A carregar...
Development of a competitive enzyme-linked immunosorbent assay for therapeutic drug monitoring of afatinib
Afatinib is an oral tyrosine kinase inhibitor (TKI) approved for treating advanced non-small cell lung cancer. It is necessary to develop a simple quantification method for TKIs in order to facilitate therapeutic drug monitoring (TDM) in clinical settings. This study sought to develop a simple and s...
Na minha lista:
| Publicado no: | J Pharm Anal |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Xi'an Jiaotong University
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6355467/ https://ncbi.nlm.nih.gov/pubmed/30740257 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpha.2018.09.002 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|